$CRNT 4 SEC Filings

Filed On	Filing
15 Jun 2026	Form 4: Makov Efrat, Director Received 5,000 shares by exercise or conversion ($9.95K) · Sold 5,000 shares ($15K)
15 Jun 2026	Form 4: Arazi Doron Ovadia, Chief Executive Officer Received 66,667 shares as a grant or award · Granted 133,333 Stock Option (Right to Buy)
26 May 2026	Form 4: Rosen Ilan, Director Received 9,770 shares as a grant or award · Granted 19,540 Stock Option (Right to Buy) · Received 22,120 shares as a grant or award · 1 more
26 May 2026	Form 4: Hadar Rami, Director Received 6,520 shares as a grant or award · Granted 13,030 Stock Option (Right to Buy) · Received 14,750 shares as a grant or award · 1 more
26 May 2026	Form 4: Makov Efrat, Director Received 6,520 shares as a grant or award · Received 6,667 shares by exercise or conversion ($14.1K) · Sold 6,667 shares ($17.7K) · 3 more
26 May 2026	Form 4: Wadsworth Robert M, Director Received 6,530 shares as a grant or award · Granted 13,050 Stock Option (Right to Buy) · Received 14,100 shares as a grant or award · 1 more
26 May 2026	Form 4: Ripstein David, Director Received 6,520 shares as a grant or award · Granted 13,030 Stock Option (Right to Buy) · Received 14,750 shares as a grant or award · 1 more
26 May 2026	Form 4: Liran Shlomo, Director Received 6,520 shares as a grant or award · Granted 13,030 Stock Option (Right to Buy) · Received 14,750 shares as a grant or award · 1 more
26 May 2026	Form 4: Shaham Yael, Director Received 6,520 shares as a grant or award · Granted 13,030 Stock Option (Right to Buy) · Received 14,750 shares as a grant or award · 1 more
25 Mar 2026	Form 4: Stein Ronen, Chief Financial Officer Received 17,417 shares as a grant or award · Granted 34,833 Stock Option (Right to Buy)
25 Mar 2026	Form 4: Ben-hamou Ronen, Chief Revenue Officer Received 27,213 shares as a grant or award · Granted 54,427 Stock Option (Right to Buy)

Comments